Breaking News

Actavis Appoints Chief Accounting Officer

August 16, 2013

D'Arecca brings extensive industry experience

James D'Arecca has been appointed chief accounting officer at Actavis, Inc. He reports to R. Todd Joyce, global chief financial officer. Mr. D'Arecca joins the company from Bausch & Lomb, where he served in a similar role to his new position at Actavis.
 
Prior to Bausch & Lomb, he served as executive director and business development controller at Merck, where he was the primary liaison between the controller's organization and the business development and corporate licensing functions. Previously, Mr. D'Arecca was executive director and assistant controller at Schering-Plough. He also spent 13 years with PricewaterhouseCoopers, with a focus on pharmaceuticals, medical devices and consumer products.
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision